Pure Global

BIOSCIENCES SAS - Authorized Company ProfileBIOSCIENCES SAS

Explore comprehensive authorized company profile for BIOSCIENCES SAS through Pure Global AI's free Colombia medical device database. This company manufactures 405 medical devices registered with INVIMA across 5 risk classes. Their registration history spans from Mar 08, 2022 to Feb 12, 2034.

This page provides detailed insights including recent registrations, risk class distribution (II: 263, Unspecified: 44, III: 53, and more), and complete regulatory information from the official Colombia INVIMA medical device database with bilingual Spanish/English support. Pure Global AI offers free access to Colombia's complete medical device registry.

Free Authorized Company Profile
Powered by Pure Global AI
405 Devices
5 Risk Classes
BIOSCIENCES SAS
BIOSCIENCES SAS
Authorized Company
405
Total Devices
5
Risk Classes
2022
Earliest
2034
Latest
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Recent Registrations
Latest 20 INVIMA device registrations

DRY FLUORESCENCE IMMUNOASSAY ANALYZER

DRY FLUORESCENCE IMMUNOASSAY ANALYZER

0cb1275646090116238393beb983dab3

IIa

LIFECODES CLASS II IDV2_x000D_

LIFECODES CLASS II IDV2_x000D_

1916242929d5b13a2c2e15409633ad51

III

LIFECODES HLA-DQA1/B1 SSO TYPING KIT

LIFECODES HLA-DQA1/B1 SSO TYPING KIT

4f3bfb96fc20b71c5899f87070e1e122

III

1. DHEA ELISA

1. DHEA ELISA

9d7c4419ac2bd60ecc34e4cb0275f762

II
Feb 12, 2034

1. ADENOSINE DEAMINASE (ADA) ASSAY

1. ADENOSINE DEAMINASE (ADA) ASSAY

a81b3f8dc554eadc0415460d59ee96fb

II
Dec 13, 2033

MATCH IT! ANTIBODY - SOFTWARE AVANZADO PARA EVALUACIÓN DE PRUEBAS DE HLA

MATCH IT! ANTIBODY - ADVANCED HLA TEST ASSESSMENT SOFTWARE

de40b071540798849a3b8701f2279012

IIa
Nov 02, 2033

MATCH IT! DNA SOFTWARE - SOFTWARE AVANZADO PARA EVALUACIÓN DE PRUEBAS DE HLA

MATCH IT! DNA SOFTWARE - ADVANCED HLA TEST EVALUATION SOFTWARE

3b11a77ebd67e9837f72ea21d642fb66

IIa
Oct 10, 2033

DRY FLUORESCENCE IMMUNOASSAY ANALYZER/ ANALIZADOR DE INMUNOENSAYO DE FLUORESCENCIA EN SECO

DRY FLUORESCENCE IMMUNOASSAY ANALYZER

e3006df124860e1067f98f966c2dbd12

IIa
Oct 05, 2033

THUNDERBOLT EIA/EIA-CL ELISA ANALYZER - EQUIPO AUTOMATIZADO PARA PROCESAMIENTO EIA/CLIA

THUNDERBOLT EIA/EIA-CL ELISA ANALYZER - AUTOMATED EQUIPMENT FOR EIA/CLIA PROCESSING

8d4ca9014d2d4d1472020753a7ebd2b4

IIa
Jun 23, 2033

1. CD20 (L26)

1. CD20 (L26)

c64af6f437223e8328656e4c989e3248

II
Jun 14, 2033

LIFECODES NON-HLA ANTIBODY KIT (IMMUCOR)

LIFECODES NON-HLA ANTIBODY KIT (IMMUCOR)

f862f84fc66e3493c2f983a5a32a5a3f

Jun 07, 2033

RIDA QLINE SCAN - ESCANER PARA USO DIAGNÓSTICO IN VITRO PARA LECTURA DE PRUEBAS DE ALERGIAS

RIDA QLINE SCAN - IN VITRO DIAGNOSTIC SCANNER FOR ALLERGY TEST READING

f4dc1bb16aa226eedc8dd74c283f2762

IIa
May 09, 2033

1. IDS JO-1

1. IDS JO-1

981d693ba56c3df187ec81fe4a5df7c9

II
Mar 24, 2033

DIAZYME HUMAN KAPPA (K) FREE LIGHT CHAIN ASSAY

DIAZYME HUMAN KAPPA (K) FREE LIGHT CHAIN ASSAY

58c809fe28e9c316e400a203f8b97a0b

II
Feb 03, 2033

QUICGMTM ASPERGILLUS GALACTOMANNAN AG LATERAL FLOW ASSAY

QUICGMTM ASPERGILLUS GALACTOMANNAN AG LATERAL FLOW ASSAY

09bfeac4eabaf84d87e6e4e9660f3e5b

II
Jan 06, 2033

IDS CALPROTECTIN

IDS CALPROTECTIN

d8037a59cc55e27d6048e8cc58306992

II
Nov 24, 2032

1. IDS T-TG IGA

1. IDS T-TG IGA

9eeaad18f69dc3f6b786e12ad4a3bd59

II
Nov 24, 2032

IDS-I10 / SISTEMA MULTIDISCIPLINAR AUTOMATIZADO PARA EL DIAGNÓSTICO IN VITRO

IDS-I10 / AUTOMATED MULTIDISCIPLINARY SYSTEM FOR IN VITRO DIAGNOSTICS

13246bdd7d3d1026d7170b678819e424

IIa
Sep 27, 2032

IDS CALPROTECTIN EXTRACTION DEVICE - DISPOSITIVO DE EXTRACCIÓN DE CALPROTECTINA

IDS CALPROTECTIN EXTRACTION DEVICE - DISPOSITIVO DE EXTRACCIÓN DE CALPROTECTINA

e6dbb64f558fc41be0991e17873964d6

I
Sep 19, 2032

NADAL® I-VTM COLLECTION AND TRANSPORT KIT (FLOCKED) - KIT DE RECOLECCIÒN Y TRANSPORTE NADAL® I-VTM (FLUIDO)

NADAL® I-VTM COLLECTION AND TRANSPORT KIT (FLOCKED)®

b4f1ff7e04e3f8f65be12fbd4a6a87c8

I
Dec 24, 2031
Risk Class Distribution
Devices by risk class
II
263
64.9% of total
III
53
13.1% of total
Unspecified
44
10.9% of total
I
32
7.9% of total
IIa
13
3.2% of total